Biovica International
15.9.2021 08:21:46 CEST | ACCESS Newswire | Press release
UPPSALA, SE / ACCESSWIRE / September 15, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)
Biovica, active in cancer diagnostics, today announces that DiviTum®TKa results from an analysis of samples from the large SWOG S0226 study have been published in the highly ranked peer-reviewed scientific journal Clinical Cancer Research, published by the American Association for Cancer Research (AACR). The strong results support using DiviTum®TKa as a tool to monitor disease progression with endocrine therapy in women with hormone receptor positive metastatic breast cancer.
"SWOG researchers have demonstrated that a blood serum test can identify which of these patients have slow-growing disease that might be controlled with a simple aromatase inhibitor pill alone," said co-author of the paper, Dr. Lajos Pusztai, MD, PhD, Yale University Cancer Center.
"We are very proud to see the strong DiviTum®TKa results being published in Clinical Cancer Research. This highly reputable scientific journal by AACR focuses on innovative clinical and translational research bridging the laboratory and the clinic. The publication is a great recognition for DiviTumTKa and an important step to establishing the test as a standard tool for monitoring treatment of metastatic breast cancer to the benefit of patients and payers," said Anders Rylander, CEO of Biovica.
As previously announced, results demonstrate that patients with low TKa levels (using a predefined cut-off) before treatment initiation will do significantly better than patients expressing high levels of TKa. Progression free survival (PFS) was 17.3 vs 11.2 months and overall survival (OS) was 58 vs 30 months, respectively. In addition, similar results were observed during treatment, where patients with low TKa showed significantly longer PFS and OS. Furthermore, results support the potential clinical use of DiviTum®TKa to identify low-TKa patients as best suited for endocrine monotherapy, whereas those with elevated TKa values appear to benefit from combination therapies.
The analysis measured thymidine kinase activity (TKa) levels in 1,726 serum samples from more than 400 patients in SWOG S0226 and is the largest study to evaluate DiviTum®TKa for prognostic and serial monitoring of metastatic breast cancer. The study constitutes the foundation for the clinical validation of DiviTum®TKa in Biovica's 510(k)-application to the FDA. DiviTum®TKa is 510(k) pending. Not available for sale in the United States.
Link to study: Clinical Cancer Research
Contact
Anders Rylander, CEO
Phone: +46-18-444 48 35
E-mail: anders.rylander@biovica.com
Biovica - Treatment decisions with greater confidence
Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments. Biovica's assay DiviTum® measure cell proliferation by detecting a biomarker in the blood stream. The assay has successfully demonstrated its capabilities to early evaluate therapy effectiveness in several clinical trials. The first application for DiviTum is monitoring of treatment for patients with metastatic breast cancer. Biovica's vision is that all cancer patients will get an optimal treatment from day one. Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum is CE-marked and registered with the Swedish Medical Products Agency. Biovica's shares are traded on the Nasdaq First North Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser, info@fnca.se , +46 8 528 00 399. For more information please visit: www.biovica.com .
SOURCE: Biovica International
View source version on accesswire.com:
https://www.accesswire.com/664165/DiviTumRTKa-Results-from-SWOG-Study-Published-in-Clinical-Cancer-Research
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Valsoft Corporation Strengthens Its Retail Software Portfolio with the Acquisition of NedFox2.4.2026 15:00:00 CEST | Press release
MONTRÉAL, QC / ACCESS Newswire / April 2, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, is pleased to announce the acquisition of NedFox, the Netherlands-based software producer of RetailVista, a comprehensive Retail ERP platform designed to support modern retail operations. Headquartered in the Netherlands, NedFox develops and markets RetailVista, an integrated cloud-based Retail ERP solution that enables retailers to manage point-of-sale, inventory, purchasing, financial administration, and reporting within a unified environment. With a strong focus on continuous innovation and customer-driven development, NedFox has built a reputation for delivering reliable, scalable software tailored to the evolving needs of retail businesses. "NedFox has built a robust and highly regarded Retail ERP platform with RetailVista, supported by a passionate team and a strong customer focus,"
Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care2.4.2026 14:10:00 CEST | Press release
Gedeon Richter's Side-by-Side Conference on Advancing Women's Health brought together Healthcare practitioners from 40 countries for a dynamic two-day exchange on March 26-27, making it the largest event of its kind ever organized by the company. BUDAPEST, HU / ACCESS Newswire / April 2, 2026 / Developed in collaboration with internationally recognized experts and grounded in peer-reviewed data, the program provided evidence-based updates on recent advances and innovations across key therapeutic areas, underscoring scientific integrity and evidence-based discussions. Beyond the science, the conference brought into focus how effective communication between healthcare professionals and patients can lead to improved diagnostic accuracy, treatment adherence, and overall patient satisfaction, as emphasized during his keynote lecture by Sukhbir Sony Singh, Full Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa. Day 1 focused on endometriosis and u
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo2.4.2026 13:00:00 CEST | Press release
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the Division I National Intercollegiate Championship (NIC), held March 19-22, 2026, near Dallas, Texas, at the Prestonwood Polo & Country Club. As the highest level of collegiate polo in the United States, the NIC brings together the nation's top student-athletes to compete for national titles.2026 Division I Women's National Intercollegiate Champions, University of South Carolina - Aiken Polo Team Winifred Branscum, Madison Jordan, and Brianna Jordan; 2026 Division I Men's National Intercollegiate Champions, University of North Texas Polo Team Alec Felhaber, Niklaus Felhaber, Johann Felhaber, Mosiah Gravesande, Sebastian Celis Guerrero Photo Credit: @oanaphoto As a proud supporter of the USPA's Intercollegiate/Interscholastic (I/I) Program,
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform1.4.2026 17:50:00 CEST | Press release
DVLT × Demora Foundation: Datavault AI's Enterprise AI Stack Deployed as the Data Intelligence & RWA Tokenization Layer for K-Pop, K-Drama, K-Entertainment, and K-Culture IP - Serving 200M+ Hallyu Fans Across 156 Countries Through K2Global's 500+ Korean SMB Network and Three US Innovation K-Wave Cities PHILADELPHIA, PA AND WILMINGTON, DE / ACCESS Newswire / April 1, 2026 / Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institution
Stagwell Announces UNICEPTA UK and Hootsuite Strategic Partnership to Deliver Decision-Grade Media Intelligence Within the Talkwalker Platform1.4.2026 17:00:00 CEST | Press release
Bringing together advanced technology and social insights to provide enterprise-ready, decision-grade media intelligence. LONDON, GB / ACCESS Newswire / April 1, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced a strategic partnership between UNICEPTA, Stagwell's global provider of human-led, AI-fed media intelligence, and Hootsuite for their UK business. The collaboration integrates UNICEPTA UK's specialist media intelligence services into Hootsuite's Talkwalker platform environment, strengthening the intelligence capabilities available to communications leaders operating in complex, high-stakes environments. "Many FTSE 100 organisations already trust the combined UNICEPTA and Talkwalker solution. Our partnership with Hootsuite builds on that foundation - bringing together enterprise-level social intelligence with UNICEPTA's global content platform and managed services to deliver faster, more consistent and more actionable
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom